3-53758384-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001128840.3(CACNA1D):​c.3787-3614C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 152,134 control chromosomes in the GnomAD database, including 3,704 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3704 hom., cov: 32)

Consequence

CACNA1D
NM_001128840.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.765

Publications

7 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.622 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128840.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.3847-3614C>G
intron
N/ANP_000711.1Q01668-2
CACNA1D
NM_001128840.3
MANE Select
c.3787-3614C>G
intron
N/ANP_001122312.1Q01668-1
CACNA1D
NM_001128839.3
c.3787-3614C>G
intron
N/ANP_001122311.1Q01668-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.3847-3614C>G
intron
N/AENSP00000288139.3Q01668-2
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.3787-3614C>G
intron
N/AENSP00000288133.5Q01668-1
CACNA1D
ENST00000481478.2
TSL:1
c.3847-4167C>G
intron
N/AENSP00000418014.2H0Y879

Frequencies

GnomAD3 genomes
AF:
0.190
AC:
28926
AN:
152016
Hom.:
3704
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.123
Gnomad AMI
AF:
0.196
Gnomad AMR
AF:
0.255
Gnomad ASJ
AF:
0.0847
Gnomad EAS
AF:
0.641
Gnomad SAS
AF:
0.438
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.165
Gnomad OTH
AF:
0.193
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.190
AC:
28933
AN:
152134
Hom.:
3704
Cov.:
32
AF XY:
0.201
AC XY:
14927
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.123
AC:
5107
AN:
41516
American (AMR)
AF:
0.255
AC:
3895
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0847
AC:
294
AN:
3472
East Asian (EAS)
AF:
0.640
AC:
3306
AN:
5162
South Asian (SAS)
AF:
0.439
AC:
2106
AN:
4802
European-Finnish (FIN)
AF:
0.226
AC:
2393
AN:
10580
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.165
AC:
11188
AN:
68002
Other (OTH)
AF:
0.196
AC:
414
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1140
2280
3421
4561
5701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
177
Bravo
AF:
0.186
Asia WGS
AF:
0.519
AC:
1805
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.71
DANN
Benign
0.38
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12487452; hg19: chr3-53792411; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.